You are here: Company  Our history
DeutschEnglishItalian
4/23/2019 12:13 am
HENNIG ARZNEIMITTEL
Liebigstraße 1-2
65439 Flörsheim am Main
DEUTSCHLAND

Tel. +49 (0) 6145 / 508-0
Fax: +49 (0) 6145 / 508-140
E-Mail: info@hennig-am.de

Working for human health since 1898 - Our history

Max E. Hennig (1875-1945)

1898

The 23-year-old industrial chemist Max E. Hennig founds the company in 1898 in Berlin. He begins with a single liver extract and expands his range at the end of the First World War with various heart muscle extracts and his own plant-based pharma-ceuticals.

1945

During the Second World War the life's work of the now 70-year-old com-pany's founder is completely destroyed; a few months later, on August 3, 1945, Max E. Hennig dies.

1946

Supported by his employees, Hennig's long-term colleague Kurt Moschner builds the company up again in the East of Berlin. 

 

1950

As soon as Kurt Moschner notices that the firm is placed under state control and expropriation looms, he leaves the Soviet occupied zone and moves to Flörsheim am Main in the west of Germany, its current location.

Kurt Moschner (2.v.r.) in Besprechung

1951

Moschner starts from scratch a second time and succeeds in building up the firm HENNIG ARZNEIMITTEL in just three years at its new location. Next to the plant-based medicines also medicinal products with purely chemical active substances are being produced for the first time.

1982

Introduction of an original drug for the treatment of vertigo and start of a wide range of generic drugs for various indications.

Wolfram und
Helga Schleenhain

1984

After the death of Kurt Moschner in 1984, his daughter Helga and her husband Wolfram Schleenhain take over the management of the company. After the death of Kurt Moschner in 1984, his daughter Helga and her husband Wolfram Schleenhain take over management of the company. They decide to expand the company by offering contract manufacturing for other pharmaceutical companies. In addition, the own range of generic drugs is continuously widened by offering medicines for the treatment of cardiovascular diseases, lipid metabolism disorders, metabolic regulation and neurology. The expansion of tasks and the product range led to an increase of employees, resulting in several extensions of the premises and new buildings to be set up.

Holger und Dr. med. Kai Schleenhain

2006

Supported by father Wolfram, the two sons Holger and Kai Schleenhain, M. D. take over the company's management. They push on the further internationalisation of the company's original drug for the treatment of vertigo and they constantly widen the exisiting product range with numerous new active ingredients and OTC-products. Today around 280 employees work for the company, including laboratory specialists, industrial chemists, biologists and pharmacists - enabling HENNUG ARZNEIMITTEK to produce more than 600 million tablets per year.

2008

In summer 2008, the company celebrates its 110th anniversary together with representatives from local politics, science and media - and its employees, of course!

2012

The original drug for the treatment of vertigo celebrates its 30th anniversary.